ArticleJournal of the Endocrine Society2026
Revisiting the TSH range in older adults: associations between subclinical hypothyroidism and geriatric conditions.
Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond hormone deficiency: a framework for endocrine-immune-niche integration in aging skeletal muscle regeneration.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context: Thyroid-stimulating hormone (TSH) levels physiologically increase with age. Applying a fixed adult reference range to older adults may cause overdiagnosis of subclinical hypothyroidism (SCH). This study examined whether adjusting the upper limit of the TSH reference range is appropriate by evaluating reference ranges and risks of geriatric conditions in older adults. Design and Setting: We analyzed 1626 community-dwelling adults aged 65-84 years from the Bunkyo Health Study. Reference ranges for TSH, free triiodothyronine (FT3), and free thyroxine (FT4) were calculated using the 2.5th-97.5th percentiles. Participants with normal FT4 were classified into 3 groups by TSH: euthyroid (0.61-4.23 mIU/L), mild SCH (>4.23 to <7.0 mIU/L), and moderate-to-severe SCH (≥7.0 mIU/L). Associations between TSH categories and geriatric conditions were evaluated using logistic regression. Results: With increasing age, TSH tended to increase, while FT3 decreased. The 2.5th-97.5th percentile range of TSH in the total cohort was 0.49-5.56 mIU/L. After adjusting for confounders, moderate-to-severe SCH was significantly associated with cerebral microbleeds (odds ratio [OR]: 4.22, 95% CI: 1.49-11.97) and sarcopenia (OR: 3.27, 95% CI: 1.02-10.52) compared to the euthyroid group. Mild SCH was not significantly associated with any geriatric condition. Conclusion: Age-related TSH elevation is common among older adults. Mild SCH was not linked to geriatric conditions, whereas moderate-to-severe SCH showed associations with cerebral microbleeds and sarcopenia. Given the limited number of participants in this category, these findings should be interpreted cautiously and require confirmation in longitudinal studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.